文献速递血管炎自身炎症与 IgG4 相关病

磷酸二酯酶4阻断降低白塞病患者中性粒细胞活化

Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease.
PubMed 文献 · Arthritis Rheumatol · 2023-07-04

研究探讨磷酸二酯酶4(PDE4)抑制对白塞病(BD)中性粒细胞活化的影响。BD患者中性粒细胞表面活化标志物、活性氧(ROS)产生及中性粒细胞胞外诱捕网(NETs)形成均较健康供者上调,转录组分析显示1021个基因显著失调。阿普司特抑制PDE4可强烈抑制中性粒细胞表面活化标志物、ROS产生、NETosis及与先天免疫、细胞内信号和趋化相关的基因与通路。

要点

  • 白塞病患者中性粒细胞表面活化标志物(CD64、CD66b、CD11b、CD11c)、ROS产生及NETosis较健康供者上调。
  • 白塞病患者与健康供者间有1021个中性粒细胞基因显著失调,富集于先天免疫、细胞内信号和趋化通路。
  • 阿普司特抑制PDE4可强烈抑制中性粒细胞活化标志物、ROS产生、NETosis及相关基因与通路。

核心结论

  • 研究突显了阿普司特对白塞病中性粒细胞的关键生物学效应。

研究设计与样本

  • 研究比较白塞病患者与健康供者中性粒细胞,采用流式细胞术检测表面标志物和ROS产生,用转录组分析检测NETs产生和分子特征,并观察PDE4抑制前后的变化。

主要发现

  • 白塞病患者中性粒细胞表面活化标志物(CD64、CD66b、CD11b、CD11c)、ROS产生及NETosis较健康供者中性粒细胞上调。
  • 转录组分析显示白塞病患者与健康供者之间有1021个中性粒细胞基因显著失调,富集于先天免疫、细胞内信号和趋化相关通路。
  • 白塞病患者皮损中中性粒细胞浸润增加,且与PDE4共定位。
  • 阿普司特抑制PDE4后,强烈抑制中性粒细胞表面活化标志物、ROS产生、NETosis及与先天免疫、细胞内信号和趋化相关的基因与通路。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Behçet's disease (BD) is a systemic vasculitis with inflammatory lesions mediated by cytotoxic T cells and neutrophils. Apremilast, an orally available small-molecule drug that selectively inhibits phosphodiesterase 4 (PDE4), has been recently approved for the treatment of BD. We aimed to investigate the effect of PDE4 inhibition on neutrophil activation in BD. METHODS: We studied surface markers and reactive oxygen species (ROS) production by flow cytometry, and neutrophil extracellular traps (NETs) production and molecular signature of neutrophils by transcriptome analysis before and after PDE4 inhibition. RESULTS: Activation surface markers (CD64, CD66b, CD11b, and CD11c), ROS production, and NETosis were up-regulated in BD patient neutrophils compared to healthy donor neutrophils. Transcriptome analysis revealed 1,021 significantly dysregulated neutrophil genes between BD patients and healthy donors. Among dysregulated genes, we found a substantial enrichment for pathways linked to innate immunity, intracellular signaling, and chemotaxis in BD. Skin lesions of BD patients showed increased infiltration of neutrophils that colocalized with PDE4. Inhibition of PDE4 by apremilast strongly inhibited neutrophil surface activation markers as well as ROS production, NETosis, and genes and pathways related to innate immunity, intracellular signaling, and chemotaxis. CONCLUSION: We highlight key biologic effects of apremilast on neutrophils in BD.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Le Joncour A, Régnier P, Maciejewski-Duval A, et al. Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease. Arthritis Rheumatol. 2023. PMID: 36862398. doi:10.1002/art.42486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。